- Home
- USEG vs NRSN Comparison
USEG vs NRSN Comparison
Compare USEG & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- NRSN
- Stock Information
- Founded
- USEG 1966
- NRSN 2017
- Country
- USEG United States
- NRSN Israel
- Employees
- USEG N/A
- NRSN N/A
- Industry
- USEG Oil & Gas Production
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- USEG Energy
- NRSN Health Care
- Exchange
- USEG Nasdaq
- NRSN Nasdaq
- Market Cap
- USEG 42.2M
- NRSN 50.1M
- IPO Year
- USEG N/A
- NRSN 2021
- Fundamental
- Price
- USEG $1.24
- NRSN $1.74
- Analyst Decision
- USEG Strong Buy
- NRSN Buy
- Analyst Count
- USEG 1
- NRSN 2
- Target Price
- USEG $3.50
- NRSN $14.00
- AVG Volume (30 Days)
- USEG 541.2K
- NRSN 225.6K
- Earning Date
- USEG 08-11-2025
- NRSN 08-05-2025
- Dividend Yield
- USEG N/A
- NRSN N/A
- EPS Growth
- USEG N/A
- NRSN N/A
- EPS
- USEG N/A
- NRSN N/A
- Revenue
- USEG $16,340,000.00
- NRSN N/A
- Revenue This Year
- USEG $23.82
- NRSN N/A
- Revenue Next Year
- USEG N/A
- NRSN N/A
- P/E Ratio
- USEG N/A
- NRSN N/A
- Revenue Growth
- USEG N/A
- NRSN N/A
- 52 Week Low
- USEG $0.81
- NRSN $0.60
- 52 Week High
- USEG $6.40
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- USEG 44.03
- NRSN 37.19
- Support Level
- USEG $1.19
- NRSN $1.83
- Resistance Level
- USEG $1.40
- NRSN $2.09
- Average True Range (ATR)
- USEG 0.07
- NRSN 0.14
- MACD
- USEG -0.00
- NRSN -0.03
- Stochastic Oscillator
- USEG 23.81
- NRSN 11.11
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.